Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
US Stocks

ISRG Intuitive Surgical (NASDAQ) $485.85 pre-market 11 Mar 2026: AI upside?

March 11, 2026
5 min read
Share with:

ISRG stock opens pre-market at $485.85 on 11 Mar 2026, down -1.56% from the prior close. Investors are watching Intuitive Surgical, Inc. (NASDAQ: Intuitive Surgical) as AI and automation drive new product cadence and recurring instrument sales. Trading volume stands at 1,545,879 with a 50-day average of 522.86, highlighting near-term selling pressure versus the medium-term trend. We lay out the headlines, valuation, technicals, and a model-driven forecast to frame the AI stocks angle for traders and long-term investors.

ISRG stock market snapshot and price action

Intuitive Surgical, Inc. (NASDAQ: ISRG) is trading $485.85 pre-market with a one-day change of -7.71 (-1.56%). The stock opened at $493.95, with a session low/high of $484.38 / $496.00 and a 52-week range of $425.00 – $603.88. Market capitalization is about $172.54 billion in the United States market and average daily volume is 1,934,215, so today’s 1,545,879 shares represent below-average turnover. Short-term weakness sits against a longer-term uptrend where the 50-day average is $522.86 and the 200-day average is $512.50.

Sponsored

ISRG stock news and analyst sentiment

Recent filings show institutional rotations into and out of ISRG, including a reported 7.1% increase at Capital International Sarl. Analysts remain constructive: data show 16 Buy, 4 Hold, and 2 Sell ratings, supporting a consensus tilt to buy. Market commentary and coverage remain active; see the MarketWatch coverage for trading updates and MarketBeat for analyst note summaries MarketWatch MarketBeat.

ISRG stock valuation and financials

Intuitive carries a premium valuation with a trailing P/E near 61.89 and EPS of 7.85. Price-to-sales is about 17.17 and price-to-book is near 9.69, reflecting high expected earnings power and recurring instrument revenue. The company posted revenue growth of 17.24% for FY 2024 and strong margin metrics: net margin roughly 28.38% and ROE near 16.39%. Balance-sheet strength shows cash per share 16.72 and minimal debt, producing a current ratio of 4.87. These metrics explain investor willingness to pay a premium in the healthcare robotics sector.

ISRG stock technicals and trading setup

Momentum indicators show short-term weakness: RSI is 39.66 and MACD histogram slightly positive at 0.87, signaling possible stabilization but not a confirmed reversal. Bollinger Bands sit at Upper 509.78 / Middle 495.92 / Lower 482.05, so price near $485.85 is close to the band lower. ATR is 12.89, implying intraday swings can exceed $12.00. Traders should watch $482.05 (BB lower) and $520.00 (50-day MA) for breakout or rejection signals.

Meyka AI grade and ISRG stock forecast

Meyka AI rates ISRG with a score out of 100: 79.83 | Grade: B+ | Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of $585.45 versus the current $485.85, implying an upside of +20.51%. The model also lists a monthly projection of $438.35, which would imply near-term downside. Forecasts are model-based projections and not guarantees.

ISRG stock risks and AI-driven opportunities

Opportunity: Intuitive’s push into AI-enabled workflow, diagnostics (Ion system), and data services can expand recurring revenue and instrument attach rates. Risk: high valuation, potential surgical procedure cadence shifts, and competitive pressure could compress multiples. One material operational risk is slower hospital capital spending cycles; offsetting factors include product upgrades and training pathways that support replacement demand.

Final Thoughts

Key takeaways: ISRG stock trades at $485.85 pre-market on 11 Mar 2026, under short-term pressure but supported by robust margins and recurring instrument economics. Valuation is elevated with a trailing P/E near 61.89 and price-to-sales around 17.17, which prices in continued growth. Technicals suggest room for mean reversion toward the 50-day MA $522.86 if procedure volumes and guidance hold. Meyka AI’s forecast model projects $585.45 in 12 months, an implied +20.51% upside versus $485.85 today; these model-based projections are not guarantees. For AI stocks investors, the case rests on Intuitive’s ability to convert AI and automation into higher attach rates and service revenue. Watch upcoming earnings on 2026-04-21 for guidance changes, instrument sales trends, and any commentary on AI-enabled product rollouts. For more on live signals and trading tools, see our Meyka AI-powered market analysis page for ISRG: https://meyka.ai/stocks/ISRG.

FAQs

What is driving the recent ISRG stock move?

ISRG stock movement reflects near-term profit-taking, below-average volume, and mixed analyst updates. The company’s premium valuation and updates on AI-enabled products shape sentiment and trading ranges.

How does ISRG stock look on valuation?

ISRG stock trades at a high multiple with a trailing P/E around 61.89, price-to-sales near 17.17, and healthy margins. That reflects growth expectations and recurring instrument economics.

What is Meyka AI’s forecast for ISRG stock?

Meyka AI’s forecast model projects a 12-month price of $585.45, implying +20.51% upside versus the current $485.85; forecasts are model-based projections, not guarantees.

When is the next ISRG earnings report?

Intuitive Surgical’s next earnings announcement is scheduled for 2026-04-21. Watch procedure volumes, instrument sales, and AI product commentary for updated guidance and market reaction.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
12% average open rate and growing
Trusted by 4,200+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)